Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 13 studies | 25% ± 10% | |
regulatory T cell | 9 studies | 24% ± 8% | |
oligodendrocyte | 8 studies | 41% ± 15% | |
astrocyte | 7 studies | 28% ± 11% | |
epithelial cell | 6 studies | 25% ± 11% | |
type II pneumocyte | 6 studies | 28% ± 7% | |
oligodendrocyte precursor cell | 6 studies | 30% ± 14% | |
microglial cell | 5 studies | 26% ± 7% | |
fibroblast | 5 studies | 22% ± 8% | |
mucosal invariant T cell | 4 studies | 19% ± 2% | |
Mueller cell | 4 studies | 40% ± 7% | |
T cell | 4 studies | 25% ± 6% | |
adipocyte | 4 studies | 19% ± 4% | |
club cell | 4 studies | 24% ± 6% | |
macrophage | 4 studies | 25% ± 9% | |
type I pneumocyte | 4 studies | 24% ± 5% | |
cholangiocyte | 3 studies | 27% ± 8% | |
CD4-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
ciliated cell | 3 studies | 18% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 22% ± 5% | |
hepatocyte | 3 studies | 64% ± 24% | |
pericyte | 3 studies | 21% ± 7% | |
lymphocyte | 3 studies | 28% ± 13% | |
GABAergic neuron | 3 studies | 37% ± 15% | |
glutamatergic neuron | 3 studies | 41% ± 15% | |
interneuron | 3 studies | 38% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5470.44 | 245 / 245 | 100% | 58.32 | 501 / 502 |
pancreas | 100% | 2726.31 | 328 / 328 | 99% | 25.52 | 177 / 178 |
esophagus | 100% | 2065.53 | 1444 / 1445 | 99% | 29.58 | 182 / 183 |
breast | 100% | 4212.50 | 459 / 459 | 99% | 58.02 | 1109 / 1118 |
stomach | 100% | 2591.15 | 359 / 359 | 99% | 37.40 | 283 / 286 |
lung | 100% | 3205.33 | 578 / 578 | 99% | 30.22 | 1141 / 1155 |
thymus | 100% | 2505.72 | 653 / 653 | 99% | 29.16 | 597 / 605 |
intestine | 100% | 2472.77 | 966 / 966 | 99% | 39.34 | 520 / 527 |
brain | 100% | 1810.87 | 2635 / 2642 | 99% | 24.10 | 697 / 705 |
adrenal gland | 100% | 10943.82 | 258 / 258 | 98% | 42.16 | 225 / 230 |
liver | 100% | 4367.14 | 226 / 226 | 98% | 31.25 | 396 / 406 |
bladder | 100% | 2329.38 | 21 / 21 | 96% | 31.47 | 484 / 504 |
uterus | 100% | 3266.66 | 170 / 170 | 95% | 21.43 | 435 / 459 |
ovary | 100% | 2665.17 | 180 / 180 | 95% | 22.24 | 407 / 430 |
kidney | 100% | 1801.53 | 89 / 89 | 94% | 20.95 | 849 / 901 |
skin | 97% | 2141.52 | 1757 / 1809 | 97% | 26.62 | 457 / 472 |
muscle | 100% | 1659.71 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1829.40 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.36 | 1 / 1 |
adipose | 100% | 2147.12 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1828.98 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1194.14 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 23.88 | 77 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 23.87 | 43 / 45 |
peripheral blood | 91% | 2560.95 | 848 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 11.82 | 18 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0016311 | Biological process | dephosphorylation |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008432 | Molecular function | JUN kinase binding |
GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0048273 | Molecular function | mitogen-activated protein kinase p38 binding |
GO_0017017 | Molecular function | MAP kinase tyrosine/serine/threonine phosphatase activity |
GO_0051019 | Molecular function | mitogen-activated protein kinase binding |
GO_0140597 | Molecular function | protein carrier chaperone |
GO_0008330 | Molecular function | protein tyrosine/threonine phosphatase activity |
GO_0016791 | Molecular function | phosphatase activity |
GO_0033550 | Molecular function | MAP kinase tyrosine phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DUSP16 |
Protein name | protein-serine/threonine phosphatase (EC 3.1.3.16) Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) Dual specificity phosphatase 16 (Dual-specificity protein phosphatase 16) |
Synonyms | KIAA1700 MKP7 |
Description | FUNCTION: Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2. . |
Accessions | ENST00000626461 ENST00000628303.1 [Q9BY84-2] ENST00000539940.1 ENST00000626413.3 [Q9BY84-1] Q9BY84 Q8IVT8 Q32MA0 ENST00000298573.9 [Q9BY84-1] F5H5X4 ENST00000228862.3 [Q9BY84-2] |